Masanobu Oshima - Genetic Mutations

Author Information

Masanobu Oshima is a distinguished researcher affiliated with the WPI-Nano Life Science Institute (WPI-NanoLSI) at Kanazawa University, located in Kakuma, Kanazawa, Japan. His research primarily focuses on the genetic and microenvironmental factors that drive cancer progression, with a particular emphasis on colorectal and gastric cancers.

Research Contributions

Masanobu Oshima has made significant contributions to the understanding of cancer biology through his extensive research on genetic alterations and the tumor microenvironment. His work encompasses studies on mouse and organoid models to elucidate the mechanisms driving malignant progression in colorectal cancer. Additionally, he has explored the role of inflammation in gastric tumorigenesis, the orchestration of myeloid-derived suppressor cells, and the impact of chronic liver disease on gut microbiota and liver carcinogenesis. His research has provided valuable insights into the molecular pathways involved in cancer development and metastasis.

Aliases

Masanobu Oshima is also known by several aliases in academic publications, including M Oshima and M. Oshima.

Publication and Citation Metrics

Metric	Value
Total Citations	19,324
H-index	63
Number of Papers	217

Publications:

Genetic Alterations and Microenvironment that Drive Malignant Progression of Colorectal Cancer: Lessons from Mouse and Organoid Models

DOI: 10.15430/JCP.2022.27.1.1

Year: 2022

Characterization of RNF43 frameshift mutations that drive Wnt ligand‐ and R‐spondin‐dependent colon cancer

DOI: 10.1002/path.5868

Year: 2022

Malignant subclone drives metastasis of genetically and phenotypically heterogenous cell clusters through fibrotic niche generation.

DOI: 10.1038/s41467-021-21160-0

Year: 2021

STAT3-mediated upregulation of the AIM2 DNA sensor links innate immunity with cell migration to promote epithelial tumourigenesis

DOI: 10.1136/gutjnl-2020-323916

Year: 2021

FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells

DOI: 10.1038/s41388-021-01757-x

Year: 2021

Orchestration of myeloid-derived suppressor cells in the tumor microenvironment by ubiquitous cellular protein TCTP released by tumor cells.

DOI: 10.1038/s41590-021-00967-5

Year: 2021

Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope.

DOI: 10.1016/j.biomaterials.2021.121256

Year: 2021

The role of inflammation in gastric tumorigenesis

DOI: 10.1016/b978-0-323-85563-1.00012-5

Year: 2021

Stem Cells, Helicobacter pylori and Mutational Landscape - Utility of Pre-Clinical Models to Understand Carcinogenesis and to direct Management of Gastric Cancer

DOI: 10.1053/j.gastro.2021.12.252

Year: 2021

Chronic liver disease enables gut Enterococcus faecalis colonization to promote liver carcinogenesis.

DOI: 10.1038/s43018-021-00251-3

Year: 2021

Can Immunotherapy Cause Genetic Mutations?

How is the Delta F508 Mutation Inherited?

What Are the Current Research and Future Directions?

What Tools are Used for Data Analysis?

How Does Third Generation Sequencing Work?

Can Insertion Mutations Be Repaired?

How Do Genes Influence Physical Development?

What are Genetic Mutations?

What is the Role of Transversions in Evolution?

What is Data Analysis in Genetic Mutations?

Partnered Content Networks

Relevant Topics